COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis

A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of COVID-19, oxygen therapy and dexamethasone were administered. There was a possibility of thromboembolic events in this case, apixaban for prophylaxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takasaki, Kazuki, Tsunenari, Takazumi, Mori, Kazuma, Aochi, Satsuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634247/
https://www.ncbi.nlm.nih.gov/pubmed/34848425
http://dx.doi.org/10.1136/bcr-2021-246700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634247/
https://www.ncbi.nlm.nih.gov/pubmed/34848425
http://dx.doi.org/10.1136/bcr-2021-246700

Ejemplares similares